AlzeCure Pharma AB (ALZCUR.XSTO) Financials
All currency values in kr millions unless otherwise noted
Scroll
| Income Statement | TTM | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | kr 97 | kr 0 | kr 0 | kr 0 | kr 0 | kr 0 |
| Operating Income | kr 30 | -kr 48 | -kr 36 | -kr 38 | -kr 57 | -kr 78 |
| Non-Operating | ||||||
| Net Interest Expense | -kr 0 | -kr 0 | -kr 0 | -kr 0 | -kr 0 | -kr 0 |
| Income Tax Expense | -kr 0 | -kr 0 | — | — | — | — |
| Net Income | ||||||
| Net Income | kr 31 | -kr 48 | -kr 35 | -kr 37 | -kr 56 | -kr 78 |
| Per Share Data | ||||||
| Revenue Per Share | kr 0.85 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 |
| EPS (Basic) | kr 0.32 | -kr 0.41 | -kr 0.44 | -kr 0.53 | -kr 1.05 | -kr 1.83 |
| EPS (Diluted) | kr 0.32 | -kr 0.41 | -kr 0.44 | -kr 0.53 | -kr 1.05 | -kr 1.83 |
| Shares Outstanding | 114.9M | 114.8M | 81.2M | 70.1M | 53.8M | 42.6M |
AlzeCure Pharma AB (ALZCUR.XSTO) financials: revenue, profit and margins
AlzeCure Pharma AB (ALZCUR.XSTO) generated about SEK 97 million in revenue and SEK 31 million in net income (a 31.6% net margin) over the trailing twelve months. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is AlzeCure Pharma AB's (ALZCUR.XSTO) revenue?+
AlzeCure Pharma AB generated about SEK 97 million in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is AlzeCure Pharma AB profitable?+
Yes, AlzeCure Pharma AB reported about SEK 31 million in net income over the trailing twelve months, a net profit margin of roughly 31.6%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are AlzeCure Pharma AB's profit margins?+
AlzeCure Pharma AB runs an operating margin of about 31.3%, a net margin of about 31.6%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
Related stocks: Biotechnology
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ALZCUR.XSTO
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.